The  logo


  1. Blood clot risk means additional monitoring needed with patients taking ponatinib

    14 Nov 13 | 13.17 | England EU Scotland Wales

    Healthcare professionals should apply more caution to the use of ponatinib (Iclusig) and carry out additional monitoring of patients...

    more >

  2. Future populations must have new, effective antimicrobials

    13 Nov 13 | 14.22 | England EU

    It is but seven months since The Pharmaceutical Journal highlighted the growing problem of antimicrobial resistance in the weeks following a warning from Dame Sally Davies

    more >

  3. Why are there so few antibiotics in the research and development pipeline?

    13 Nov 13 | 14.09 | England EU

    Back in the 1980s, the world was seeing tens of new antibiotics being approved, but now we are lucky to see one or two products trickle through. There are many reasons why antibiotic research has dried up but, fundamentally, pharmaceutical scientists are facing a conundrum. Elizabeth Sukkar finds out that there are a number of incentives to aid the development of new antibiotics. But will society be prepared to pay the price?

    more >

  4. Time for pharmacy to unite in the fight against antimicrobial resistance

    13 Nov 13 | 10.03 | England EU Scotland Wales

    To mark European Antibiotics Awareness Day, Philip Howard, Diane Ashiru-Oredope, Mark Gilchrist and colleagues describe how pharmacy can help combat resistance

    more >

  5. EMA issues advice on IV nicardipine, after UK requests review

    11 Nov 13 | 15.31 | EU

    Intravenous nicardipine medicines should only be used to treat acute life-threatening high blood pressure and to control high blood pressure... more >

  6. Pharmacy business loses Court of Appeal case over supply of HIV drug beyond UK shores

    8 Nov 13 | 15.20 | England EU Northern Ireland Scotland Wales

    Chemistree, a UK pharmacy business that offers retail and home-care services, lost its case this week in the Court of Appeal...

    more >

  7. EMA publishes shortages catalogue

    7 Nov 13 | 16.56 | EU

    An online catalogue listing details of drugs that are in short supply in more than one EU country...

    more >

  8. EULAR updates guidelines on rheumatoid arthritis

    1 Nov 13 | 12.10 | EU

    First-line therapy for rheumatoid arthritis should be with methotrexate...

    more >

  9. Fidaxomicin endorsed by ESCMID

    31 Oct 13 | 16.35 | EU

    New European guidelines recommend fidaxomicin (Dificlir) as first-line therapy in patients...

    more >

  10. Aprotinin licence reinstated

    21 Oct 13 | 13.57 | EU

    The marketing authorisation for aprotinin has been reinstated by the European Commission...

    more >